glp-1 receptor agonist diarrhea management Effects of on changes in the gut bacterium and the underlying mechanisms Mechanisms of action of GLP-1
Description
Anti-obesity drug discovery: Advances and challenges

When subcutaneous adipose tissue loses its capacity to safely store excess energy, lipid spillover toward the liver increases, promoting hepatic steatosis

February 12, 2025

MASH Approval Could Help Change the Narrative Around Semaglutide With these results, Novo plans to file for regulatory approval of semaglutide to treat MASH in the first half of 2025
